We used the Oncomine database to analyze the expression levels of SLC22A6, SLC22A7, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 in various cancers and their normal tissues (Figure 2). This evidence concerns the gene SLC25A4 and cancer.